Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Merck
Express Scripts
McKesson

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR QUININE SULFATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Quinine Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000706 ↗ Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine Completed National Institute of Allergy and Infectious Diseases (NIAID) N/A 1969-12-31 Part I studies the effect of quinine on how zidovudine (AZT) is used by the body and eliminated through the kidneys in HIV infected patients. Part II studies the effect of probenecid and quinine on the same aspects. Because AZT leaves the bloodstream quickly, patients must take the drug frequently to keep adequate amounts in their bodies. Probenecid and quinine may slow down the rate at which AZT leaves the body. Therefore, taking these drugs along with AZT may reduce the amount of AZT needed for treatment.
NCT00726414 ↗ A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg Completed Mutual Pharmaceutical Company, Inc. Phase 1 2005-12-01 The purpose of this study is to evaluate and compare the relative bioavailability of Quinine Sulfate capsules following a single, oral dose in healthy volunteers under fasting and fed conditions.
NCT00726895 ↗ A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions Completed Mutual Pharmaceutical Company, Inc. Phase 1 2004-05-01 The purpose of this study is to evaluate and compare the dose proportionality of 324 mg Quinine Sulfate capsules following a single oral dose (1 x 324 mg capsules versus 2 x 324 mg capsules) in healthy adult volunteers when administered under fasting conditions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Quinine Sulfate

Condition Name

Condition Name for Quinine Sulfate
Intervention Trials
Healthy 8
Amyotrophic Lateral Sclerosis 2
Renal Impairment 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Quinine Sulfate
Intervention Trials
Spasm 2
Sclerosis 2
Muscle Cramp 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Quinine Sulfate

Trials by Country

Trials by Country for Quinine Sulfate
Location Trials
United States 8
Portugal 2
Switzerland 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Quinine Sulfate
Location Trials
North Dakota 2
Maryland 1
New York 1
Pennsylvania 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Quinine Sulfate

Clinical Trial Phase

Clinical Trial Phase for Quinine Sulfate
Clinical Trial Phase Trials
Phase 2/Phase 3 1
Phase 2 1
Phase 1/Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Quinine Sulfate
Clinical Trial Phase Trials
Completed 13
Terminated 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Quinine Sulfate

Sponsor Name

Sponsor Name for Quinine Sulfate
Sponsor Trials
Mutual Pharmaceutical Company, Inc. 9
Universidade do Porto 2
Cetero Research, San Antonio 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Quinine Sulfate
Sponsor Trials
Industry 9
Other 8
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Medtronic
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.